Results After Thoracic Aortic Reoperations in Marfan Syndrome Fabian A. Kari, MD, Friedhelm Beyersdorf, MD, Elizabeth H. Stephens, MD, PhD, Prisca Peter, MS, Bartosz Rylski, MD, Maximilian Russe, MD, Philipp Blanke, MD, Matthias Siepe, MD The Annals of Thoracic Surgery Volume 97, Issue 4, Pages 1275-1280 (April 2014) DOI: 10.1016/j.athoracsur.2013.12.023 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Diseases leading to secondary aortic procedures (white bar, chronic residual dissection; striped bar, new-onset distal dissection; checked bar, root or valve disease; stippled bar, progressive aneurysmal disease) stratified for primary disease in 40 patients with Marfan syndrome. Probability values were derived from analysis of variance on ranks comparing all three primary disease groups. (NS = not significant.) The Annals of Thoracic Surgery 2014 97, 1275-1280DOI: (10.1016/j.athoracsur.2013.12.023) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Overall survival of 40 patients with Marfan syndrome after secondary thoracic aortic procedures. Solid line is survival, with 95% confidence intervals shown by dashed lines. The Annals of Thoracic Surgery 2014 97, 1275-1280DOI: (10.1016/j.athoracsur.2013.12.023) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Overall freedom from central nervous deficits (composite end point including stroke and bleeding, transient and irreversible symptoms, as well as paraplegia) of 40 patients with Marfan syndrome after secondary thoracic aortic procedures. Solid line is survival, with 95% confidence intervals shown by dashed lines. The Annals of Thoracic Surgery 2014 97, 1275-1280DOI: (10.1016/j.athoracsur.2013.12.023) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions